These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 5684267)

  • 1. Chronotropic responses to catecholamines as a function of monoamine oxidase activity in the isolated perfused rat heart.
    Davis PW; Horita A
    Arch Int Pharmacodyn Ther; 1968 Jun; 173(2):386-94. PubMed ID: 5684267
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of alpha-methyldopa on the metabolism of dopamine in the striatum of the rat.
    Uretsky NJ
    J Pharmacol Exp Ther; 1974 May; 189(2):359-69. PubMed ID: 4829219
    [No Abstract]   [Full Text] [Related]  

  • 3. On the extraneuronal nature of cardiac monoamine oxidase in the rat.
    Horita A; Lowe MC
    Adv Biochem Psychopharmacol; 1972; 5():227-42. PubMed ID: 5054204
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of monoamine oxidase inhibition on catecholamine levels: evidence for synthesis but not storage of epinephrine in rat spinal cord.
    Sved AF
    Brain Res; 1990 Apr; 512(2):253-8. PubMed ID: 2354362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamine metabolism in pargyline treated rats exposed to stress.
    Prasad R; Patel V; Chansouria JP; Udupa KN
    Endocrinol Exp; 1980; 14(2):147-50. PubMed ID: 6104592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of action of adrenaline and some other biogenic amines on gamma-amylase activity of rat liver and heart muscle].
    Orlova VS; Siniukhin VN; Popova IA; Gorkin VZ; Rozenfel'd EL
    Biokhimiia; 1971; 36(3):555-61. PubMed ID: 5132486
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of vesicular storage and monoamine oxidase activity on [11C]phenylephrine kinetics: studies in isolated rat heart.
    Raffel DM; Wieland DM
    J Nucl Med; 1999 Feb; 40(2):323-30. PubMed ID: 10025842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of monoamine oxidase in determining the amount of monoamines released by drugs in the central nervous system.
    Rutledge CO; Azzaro AJ; Ziance RJ
    Adv Biochem Psychopharmacol; 1972; 5():379-92. PubMed ID: 5054209
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of intraneuronal monoamine oxidase on neuronal net uptake of noradrenaline and on sensitivity to noradrenaline.
    Trendelenburg U; Draskóczy PR; Graefe KH
    Adv Biochem Psychopharmacol; 1972; 5():371-7. PubMed ID: 5054208
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of methoxymetabolites of catecholamines on the effect of catecholamines upon isolates perfused rat's heart.
    Chruściel TL; Janiec W; Vasić B
    Arch Int Pharmacodyn Ther; 1965 Jul; 156(1):78-86. PubMed ID: 5858841
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
    Neff NH; Costa E
    J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of intraneuronal monoamine oxidase in the regulation of norepinephrine synthesis.
    Weiner N; Bjur R
    Adv Biochem Psychopharmacol; 1972; 5():409-19. PubMed ID: 4403371
    [No Abstract]   [Full Text] [Related]  

  • 13. Some considerations in the design of substrate and tissue-specific inhibitors of monoamine oxidase.
    Martin YC; Biel JH
    Adv Biochem Psychopharmacol; 1974; 12(0):37-48. PubMed ID: 4417042
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential development, inhibition, and recovery of monoamine oxidase in various parts of the rat heart.
    Horita A
    Res Commun Chem Pathol Pharmacol; 1970 Nov; 1(6):713-20. PubMed ID: 5524271
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of monoamine oxidase in the intraneuronal metabolism of norepinephrine released by indirectly-acting sympathomimetic amines or by adrenergic nerve stimulation.
    Smith CB
    J Pharmacol Exp Ther; 1966 Feb; 151(2):207-20. PubMed ID: 5932599
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monoamine oxidase and its inhibitors. Physiological, physiopathological and pharmacotherapeutic considerations].
    Constantinescu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1978; 23(4):303-12. PubMed ID: 370952
    [No Abstract]   [Full Text] [Related]  

  • 17. Substrate-selective and tissue-selective inhibition of monoamine oxidase.
    Fuller RW; Roush BW
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):270-6. PubMed ID: 5054735
    [No Abstract]   [Full Text] [Related]  

  • 18. The labeling in vivo of monoamine oxidase by 14 C-pargyline: a tool for studying the synthesis of the enzyme.
    Erwin VG; Deitrich RA
    Mol Pharmacol; 1971 Mar; 7(2):219-28. PubMed ID: 5125856
    [No Abstract]   [Full Text] [Related]  

  • 19. [Catecholamine metabolism and mitochondrial enzyme activity].
    Tapbergenov SO
    Vopr Med Khim; 1982; 28(2):52-8. PubMed ID: 6123194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Catecholamines in the mechanism of the cardionecrotic action of acetaldehyde].
    Zabirova IG; Nuzhnyĭ VP; Uspenskiĭ AE
    Biull Eksp Biol Med; 1982 Dec; 94(12):65-7. PubMed ID: 7150769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.